Victoria Socha

DocwireNews

Patients in the care of nephrologists are commonly prescribed erythropoiesis-stimulating agents (ESAs) and iron supplements. However, according to Naoki Okamoto, MD, and colleagues, there are few data detailing the differences in prescription rates of ESAs and iron supplements among non-nephrology clinical departments.The researchers conducted a study to examine prescription practices of ESAs and iron supplements among clinical departments, including nephrology. Results were <a href="https://link.springer.com/article/10.1007/s10157-022-02194-0">reported</a> online in Clinical and Experimental Nephrology [doi:10.1007/s10157-022-02194-0].A total of 39,585 patients with estimated glomerular filtration rate of &lt;60 mL/min/1.73 m2 were identified from a database of 914,280 patients. The patients were treated in any of eight clinical departments from internal medicine (including nephrology). Anemia was defined as hemoglobin level less than 11.0 g/dL and cutoff points of 20% of transferrin saturation and 100 ng/mL of serum ferritin were used. The researchers compared prescription rates of ESAs and iron supplementation based on hemoglobin level and iron status among the patients seen in the eight clinical departments.Patients with lower eGFR were more likely to seen under nephrology care. The rates of patients with no prescription for either an ESA or iron supplement were 52.3%, 39.9%, 45.9%, and 54.3% among patients with hemoglobin levels &lt;8, 8 to &lt;9, 9 to &lt;10, and &ge;10 to &lt;11 g/dL, respectively.Among patients with less than 11 g/dL of hemoglobin, 77.3% were prescribed ESAs under nephrology care. Among patients treated in clinical departments of internal medicine other than nephrology, only 18.5% of patients were prescribed an ESA. Among patients treated in clinical departments in non-internal medicine, only 8.2% were prescribed and ESA.In conclusion, the authors said, &ldquo;Treatment for anemia has not been sufficiently performed in patients with renal impairment under non-nephrology care in a real-world clinical setting.&rdquo;

Sara Nunnery, MD, MSCI

Reclassifying HER2: What Oncologists Need to Know About HER2-Low and -Ultralow Breast Cancer

HER2 Breast Cancer

Jeffrey Perl, MD

Joel M. Topf, MD, FACP

Thoughts From the 2025 Lazarus Award Winner

NKF Spring Clinical Meetings 2025

Brandon Twyford

DESTINY-Breast09 Demonstrates First-Line Superiority of Enhertu Plus Pertuzumab in HER2-Positive Metastatic Breast Cancer

Latest News

Prescription Rates of ESAs for Anemia in Non-Nephrology Care

Anemia and Kidney Disease

Patients in the care of nephrologists are commonly prescribed erythropoiesis-stimulating agents (ESAs) and iron supplements. However, according to Naoki Okamoto, MD, and ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe